[1] 王宇,周晓光,陈志均,等.早产儿视网膜病治疗研究进展[J].中华实用儿科临床杂志,2017,32(2):146-148.
[2] 李慧林,张国明,张福燕,等.早产儿视网膜病变血清代谢通路研究进展[J].眼科新进展,2016,36(9):881-884.
[3] SEYFARTH H J,SACK U,GESSNER C,et al.Angiogenin,bFGF and VEGF:angiogenic markers in breath condensate of patients with pulmonary hypertension[J].Pneumologie,2015,69(4):207-211.
[4] 陈莹,夏轶姿,龚裕强,等.社区获得性肺炎患者可溶性E选择素水平变化情况及其意义[J].中华全科医学,2017,15(11):1925-1927.
[5] 李苏亮,叶芸.E-selectin和sICAM-1在儿童肺炎支原体感染中的价值[J].山西医科大学学报,2015,46(10):1027-1029.
[6] PIEH C,KRVGER M,LAGRōZE W A,et al.Plasma sE-selectin in premature infants:a possible surrogate marker of retinopathy of prematurity[J].Invest Ophthalmol Vis Sci,2010,51(7):3709-3713.
[7] LISTED N.An international classification of retinopathy of prematurity.The Committee for the Classification of Retinopathy of Prematurity[J].Arch Ophthalmol,1984,102(8):1130-1134.
[8] 高宏程,陈晨,张迎秋,等.早产儿视网膜病变的危险因素研究进展[J].国际眼科杂志,2018(1):80-83.
[9] VANDERVEEN D K,MELIA M,YANG M B,et al.Anti-vascular endothelial growth factor therapy for primary treatment of type 1 retinopathy of prematurity:a report by the American Academy of Ophthalmology[J].Ophthalmology,2017,124(5):619-633.
[10] 张军,刘森玉.VEGF和bFGF在蒙古族糖尿病视网膜病变中的表达[J].国际眼科杂志,2016,16(7):1313-1315.
[11] LI J K,WEI F,JIN X H,et al.Changes in vitreous VEGF,bFGF and fibrosis in proliferative diabetic retinopathy after intravitreal bevacizumab[J].Int J Ophthalmol,2015,8(6):1202-1206.
[12] 郑靖阳,肖秀漫,陈清,等.血清IGF-1、bFGF及VEGF浓度与早产儿视网膜病的关系[J].医学研究杂志,2015,44(11):153-156.
[13] 杨小凤,陈超.血管生成相关因子在早产儿视网膜病外周循环中的表达[J].中华围产医学杂志,2016,19(7):552-556.
[14] 薛晓辉,马庆祥.血清VEGF与SE-选择素在糖尿病视网膜病变患者中的表达及意义[J].陕西医学杂志,2016,45(10):1316-1317.
[15] CETINKAYA M,EREN-ERERCAN T,CANSEV M,et al.The utility of serial plasma sE-selectin measurements in the prediction of retinopathy of prematurity in premature infants[J].Early Human Development,2014,90(9):517-521. |